TrialBlood advances2018

Phase 2 trial of a multivalent WT1 peptide vaccine (galinpepimut-S) in acute myeloid leukemia.

Peter G Maslak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.